Efficacy of Muscle Exercise in Patients with Muscular Dystrophy: A Systematic Review Showing a Missed Opportunity to Improve Outcomes

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Gianola, Silvia ^a   Pecoraro, Valentina ^a   Lambiase, Simone ^b   Gatti, Roberto ^c   Banfi, Giuseppe ^a,d   Moja, Lorenzo ^a,d  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BECKER MUSCULAR DYSTROPHY; CLINICAL EFFECTIVENESS; DUCHENNE MUSCULAR DYSTROPHY; ENDURANCE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FATIGUE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MOTOR PERFORMANCE; MUSCLE EXERCISE; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; MYOTONIC DYSTROPHY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; EXERCISE; MUSCULAR DYSTROPHIES; PHYSIOLOGY; QUALITY OF LIFE;

SCOPUS;

EXERCISE; HUMANS; MUSCLE STRENGTH; MUSCULAR DYSTROPHIES; QUALITY OF LIFE;

EID: 84878913149     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065414     Document Type: Article

References (56)

1. Sutton AL (2009) Movement Disorders Sourcebook: Basic Consumer Health Information about the Symptoms and Causes of Movement Disorders: Omnigraphics.
2. Natterlund B, Ahlstrom G, (2001) Activities of daily living and quality of life in persons with muscular dystrophy. J Rehabil Med 33: 206-211.
3. Engvall E, Wewer UM, (2003) The new frontier in muscular dystrophy research: booster genes. FASEB J 17: 1579-1584.
4. Sarparanta J, Jonson PH, Golzio C, Sandell S, Luque H, et al. (2012) Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy. Nat Genet 44: 450-455, S451-452.
5. Scime A, Rudnicki MA, (2008) Molecular-targeted therapy for Duchenne muscular dystrophy: progress and potential. Mol Diagn Ther 12: 99-108.
6. Ansved T, (2001) Muscle training in muscular dystrophies. Acta Physiol Scand 171: 359-366.
7. Lindeman E, Spaans F, Reulen J, Leffers P, Drukker J, (1999) Progressive resistance training in neuromuscular patients. Effects on force and surface EMG. J Electromyogr Kinesiol 9: 379-384.
8. Naugle KM, Fillingim RB, Riley JL 3rd (2012) A Meta-Analytic Review of the Hypoalgesic Effects of Exercise. J Pain.
9. Ferreira ML, Sherrington C, Smith K, Carswell P, Bell R, et al. (2012) Physical activity improves strength, balance and endurance in adults aged 40-65 years: a systematic review. J Physiother 58: 145-156.
10. Brazzelli M, Saunders DH, Greig CA, Mead GE (2011) Physical fitness training for stroke patients. Cochrane Database Syst Rev: CD003316.
11. Pak S, Patten C, (2008) Strengthening to promote functional recovery poststroke: an evidence-based review. Top Stroke Rehabil 15: 177-199.
12. Snook EM, Motl RW, (2009) Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair 23: 108-116.
13. Johnson EW, Braddom R, (1971) Over-work weakness in facioscapulohuumeral muscular dystrophy. Arch Phys Med Rehabil 52: 333-336.
14. Wagner MB, Vignos PJ Jr, Fonow DC, (1986) Serial isokinetic evaluations used for a patient with scapuloperoneal muscular dystrophy. A case report. Phys Ther 66: 1110-1113.
15. Fowler WM Jr, (1984) Importance of overwork weakness. Muscle Nerve 7: 496-499.
16. Petrof BJ, (1998) The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem 179: 111-123.
17. Reeves BC DJ, Higgins JPT, Wells GA (2011) Chapter 13: Including non-randomized studies, in Cochrane Handbook for Systematic Reviews of Interventions; JPT H, editor: The Cochrane Collaboration.
18. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
19. Higgins JPT, Green S, editors (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available: www.cochrane-handbook.org. Accessed 2012 Aug.
20. Fowler (1965) Ineffective treatment of muscular dystrophy with an anabolic steroid and other measures. New England Journal of Medicine 272: 875-882.
21. Moon JH, Na YM, Kang SW, Lee HS, (1996) The changes in muscle strength and relaxation time after a comprehensive rehabilitation program for patients with myotonic dystrophy. Yonsei Med J 37: 237-242.
22. Sjogreen L, Tulinius M, Kiliaridis S, Lohmander A, (2010) The effect of lip strengthening exercises in children and adolescents with myotonic dystrophy type 1. Int J Pediatr Otorhinolaryngol 74: 1126-1134.
23. Hoberman M, (1955) Physical medicine and rehabilitation: its value and limitations in progressive muscular dystrophy. Am J Phys Med 34: 109-115.
24. Abrahamson AS, Rogoff J (1952) Physical treatment in muscular dystrophy. Proc Second Med Conf MDAA: 123±124.
25. Wratney MJ (1958) Physical therapy for muscular dystrophy children Phys Ther Rev 26±32.
26. Aldehag AS, Jonsson H, Ansved T, (2005) Effects of a hand training programme in five patients with myotonic dystrophy type 1. Occup Ther Int 12: 14-27.
27. Edwards RH, Chapman SJ, Newham DJ, Jones DA, (1987) Practical analysis of variability of muscle function measurements in Duchenne muscular dystrophy. Muscle Nerve 10: 6-14.
28. Alemdaroǧlui I, Karaduman AA, Yilmaz Ö, (2012) Acute effects of different exercises on hemodynamic responses and fatigue in Duchenne muscular dystrophy2012. Fizyoterapi Rehabilitasyon 23: 10-16.
29. Kilmer DD, Aitkens SG, Wright NC, McCrory MA, (2001) Response to high-intensity eccentric muscle contractions in persons with myopathic disease. Muscle Nerve 24: 1181-1187.
30. Florence JM, Pandya S, King WM, Robison JD, Signore LC, et al. (1984) Clinical trials in Duchenne dystrophy. Standardization and reliability of evaluation procedures. Phys Ther 64: 41-45.
31. Sveen ML, Jeppesen TD, Hauerslev S, Krag TO, Vissing J, (2007) Endurance training: an effective and safe treatment for patients with LGMD2I. Neurology 68: 59-61.
32. Sveen ML, Jeppesen TD, Hauerslev S, Kober L, Krag TO, et al. (2008) Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Brain 131: 2824-2831.
33. Olsen DB, Orngreen MC, Vissing J, (2005) Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 64: 1064-1066.
34. Scott OM, Hyde SA, Goddard C, Jones R, Dubowitz V, (1981) Effect of exercise in Duchenne muscular dystrophy. Physiotherapy 67: 174-176.
35. van der Kooi EL, Kalkman JS, Lindeman E, Hendriks JCM, van Engelen BGM, et al. (2007) Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. Journal of Neurology 254: 931-940.
36. Jansen M, de Groot IJ, van Alfen N, Geurts A, (2010) Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study. BMC Pediatr 10: 55.
37. Voet NB, Bleijenberg G, Padberg GW, van Engelen BG, Geurts AC, (2010) Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial. BMC Neurol 10: 56.
38. van der Kooi EL, Vogels OJ, van Asseldonk RJ, Lindeman E, Hendriks JC, et al. (2004) Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology 63: 702-708.
39. Lindeman E, Leffers P, Spaans F, Drukker J, Reulen J, et al. (1995) Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil 76: 612-620.
40. Kierkegaard M, Harms-Ringdahl K, Edstrom L, Widen Holmqvist L, Tollback A, (2011) Feasibility and effects of a physical exercise programme in adults with myotonic dystrophy type 1: a randomized controlled pilot study. J Rehabil Med 43: 695-702.
41. Tollback A, Eriksson S, Wredenberg A, Jenner G, Vargas R, et al. (1999) Effects of high resistance training in patients with myotonic dystrophy. Scand J Rehabil Med 31: 9-16.
42. de Lateur BJ, Giaconi RM, (1979) Effect on maximal strength of submaximal exercise in Duchenne muscular dystrophy. Am J Phys Med 58: 26-36.
43. Genetic home reference, Myotonic dystrophy. Available: http://ghr.nlm.nih.gov/condition Accessed 2012 Aug.
44. Harper PS (2001) Myotonic dystrophy: W. B. Saunders.
45. Kubiakc D-M (2011) European Perspective. The European Clnical research infrastructures network. Ann Oncol Suppl 7.
46. Vignos PJ Jr, (1983) Physical models of rehabilitation in neuromuscular disease. Muscle Nerve 6: 323-338.
47. Smith SM, Soubhi H, Fortin M, Hudon C, O'Dowd T, (2012) Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ 345: e5205.
48. Liberati A, (2011) Need to realign patient-oriented and commercial and academic research. Lancet 378: 1777-1778.
49. van't Riet A, Berg M, Hiddema F, Sol K, (2001) Meeting patients' needs with patient information systems: potential benefits of qualitative research methods. Int J Med Inform 64: 1-14.
50. Chalmers I, Glasziou P, Godlee F, (2013) All trials must be registered and the results published. BMJ 346: f105.
51. Chalmers I, (2003) The James Lind Initiative. J R Soc Med 96: 575-576.
52. The James Lind Alliance, How the James Lind Alliance Works. Available: http://www.lindalliance.org. Accessed 2012 Dec.
53. Munn J, Herbert RD, Gandevia SC, (2004) Contralateral effects of unilateral resistance training: a meta-analysis. J Appl Physiol 96: 1861-1866.
54. Evetovich TK, Housh TJ, Housh DJ, Johnson GO, Smith DB, et al. (2001) The effect of concentric isokinetic strength training of the quadriceps femoris on electromyography and muscle strength in the trained and untrained limb. J Strength Cond Res 15: 439-445.
55. Hortobagyi T, Lambert NJ, Hill JP, (1997) Greater cross education following training with muscle lengthening than shortening. Med Sci Sports Exerc 29: 107-112.
56. Voet NB, van der Kooi EL, Riphagen, II, Lindeman E, van Engelen BG, et al. (2010) Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev: CD003907.